BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 30991994)

  • 1. The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax.
    Jacheć W; Tomasik A; Kurzyna M; Pietura R; Torbicki A; Głowacki J; Nowalany-Kozielska E; Wojciechowska C
    BMC Pulm Med; 2019 Apr; 19(1):80. PubMed ID: 30991994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Pulmonary Hypertension Due to Fistulas Between Multiple Systemic Arteries and the Right Pulmonary Artery in an Adult Discovered for Occulted Dyspnoea.
    Li JF; Zhai ZG; Kuang TG; Liu M; Ma ZH; Li YD; Yang YH
    Heart Lung Circ; 2017 Aug; 26(8):e54-e58. PubMed ID: 28314671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac catheterization and pulmonary vasoreactivity testing in children with idiopathic pulmonary arterial hypertension].
    Zhang C; Li Q; Liu T; Gu H
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):468-72. PubMed ID: 25190170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiography based estimation of pulmonary vascular resistance in patients with pulmonary hypertension: a simultaneous Doppler echocardiography and cardiac catheterization study.
    Lindqvist P; Söderberg S; Gonzalez MC; Tossavainen E; Henein MY
    Eur J Echocardiogr; 2011 Dec; 12(12):961-6. PubMed ID: 22011836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaso reactivity test using inhaled nitric oxide for pulmonary arterial hypertension accompanied by severe interstitial lung disease attributed to systemic sclerosis: A case report.
    Yamaguchi T; Izumiya Y; Hayashi O; Hayashi H; Ogawa M; Shibata A; Yamazaki T; Yoshiyama M
    J Cardiol Cases; 2022 Mar; 25(3):144-148. PubMed ID: 35261697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of pulmonary hypertension on early hemodynamics after orthotopic heart transplantation].
    Liu MZ; Wang JH; Du J; Huang J; Li LH
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2618-22. PubMed ID: 18162149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
    Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
    Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Ishihara S; Kioka H; Ohtani T; Asano Y; Yamaguchi O; Hikoso S; Toda K; Saito Y; Sawa Y; Yamauchi-Takihara K; Sakata Y
    Pulm Circ; 2018; 8(3):2045894018770131. PubMed ID: 29575985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.
    Ghofrani HA; Wiedemann R; Rose F; Olschewski H; Schermuly RT; Weissmann N; Seeger W; Grimminger F
    Ann Intern Med; 2002 Apr; 136(7):515-22. PubMed ID: 11926786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sildenafil reduces pressure and pulmonary resistance and increases susceptibility of pulmonary arteries to nitric oxide in primary pulmonary arterial hypertension].
    Wodniecki J; Jacheć W; Poloński L; Tomasik AR; Wojciechowska C; Foremny A
    Przegl Lek; 2005; 62(2):135-8. PubMed ID: 16095162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
    Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbruck B; Grimminger F; Seeger W
    Am J Respir Crit Care Med; 1999 Aug; 160(2):600-7. PubMed ID: 10430735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.
    Lyle MA; Fenstad ER; McGoon MD; Frantz RP; Krowka MJ; Kane GC; Swanson KL
    Chest; 2016 Feb; 149(2):362-371. PubMed ID: 26204445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There Value in Repeating Inhaled Nitric Oxide Vasoreactivity Tests in Patients with Pulmonary Arterial Hypertension?
    Tooba R; Almoushref A; Tonelli AR
    Lung; 2020 Feb; 198(1):87-94. PubMed ID: 31894408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.
    Antoniou T; Prokakis C; Athanasopoulos G; Thanopoulos A; Rellia P; Zarkalis D; Kogerakis N; Koletsis EN; Bairaktaris A
    Ann Thorac Surg; 2012 Sep; 94(3):792-8. PubMed ID: 22727248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular parameters of chest CT scan in estimating pulmonary arterial pressure in patients with pulmonary hypertension.
    Li M; Wang S; Lin W; Li J; Wang C; Chen H; Lu W; Yang K; Wang J; Zeng Q
    Clin Respir J; 2018 Feb; 12(2):572-579. PubMed ID: 27696745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
    Wang L; Jin YZ; Zhao QH; Jiang R; Wu WH; Gong SG; He J; Liu JM; Jing ZC
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3353-3360. PubMed ID: 29200842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary artery acceleration time in identifying pulmonary hypertension patients with raised pulmonary vascular resistance.
    Tossavainen E; Söderberg S; Grönlund C; Gonzalez M; Henein MY; Lindqvist P
    Eur Heart J Cardiovasc Imaging; 2013 Sep; 14(9):890-7. PubMed ID: 23295626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.